Therapeutic doses of Viagra® have been shown to influence the rate at which visual signals are integrated by the brain, affecting the way quick, repeated events, such as flickering light, are perceived. The work sheds light on the function of a specific photoreceptor enzyme and paves the way for future research utilizing Viagra as a safe tool for studying human vision.
Originally developed as a heart drug, sildenafil citrate (Viagra®) has several side effects, not least of which is that it helps to alleviate erectile dysfunction by prolonging the relaxation of smooth muscle in the corpora cavernosa of the penis, thereby helping to maintain the blood flow required for an erection. A less desirable side effect is that it inhibits the enzyme phosphodiesterase, PDE6, which is in the cone and rod photoreceptors of the eye and is involved in the transduction of photons into neural signals that are decoded by the visual system. The precise effect of Viagra on human visual performance, however, remains somewhat equivocal and anecdotal.
By measuring the ability of human observers to detect flickering lights under various conditions, a team of researchers, including Andrew Stockman of the Institute of Ophthalmology, London, has demonstrated that therapeutic 100 mg doses of Viagra cause transient losses in the sensitivity to flicker. These losses range in severity, from mild to moderate, among observers. In those more affected observers, the losses in flicker sensitivity caused by the inhibition of PDE6 by Viagra are consistent with an almost doubling of the time over which visual events are integrated by the visual system.
These results demonstrate the importance of PDE6 not only in transduction, but also in light adaptation: PDE6 normally helps to maintain the visual response within an optimal range by shortening the time over which visual responses are integrated as the light level increases. When the integration time is not appropriately reduced with light level--for example, owing to the inhibition of PDE6 by Viagra--the integrated visual response becomes too large and the eye's temporal resolution too low. Thanks to these detrimental effects, Viagra represents a unique tool for the scientist to manipulate the activity of PDE6 pharmacologically in humans in vivo, and thus to investigate the role of this enzyme in vision.
The researchers include Andrew Stockman, Lindsay T. Sharpe, and Glen Jeffery of the University College London in London, United Kingdom; Adnan Tufail of Moorfields Eye Hospital in London, United Kingdom; Philip D. Kell of Middlesex Hospital in London, United Kingdom. This work was supported by a Wellcome Trust awarded to A.S.
Stockman et al.: "Viagra slows the visual response to flicker." Current Biology 16, pages R44-R45, January 24, 2006 DOI 10.1016/j.cub.2006.01.016 www.current-biology.com
Cite This Page: